Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris
Public ClinicalTrials.gov record NCT01182636. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Multiple-Site, Placebo Controlled, Parallel Design, Clinical Study to Evaluate the Bioequivalence of Adapalene Gel 0.1% (PLIVA Research & Development Ltd.) Compared to Differin® (Adapalene 0.1%) Topical Gel (Galderma Laboratories) in Patients With Acne Vulgaris
Study identification
- NCT ID
- NCT01182636
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Teva Pharmaceuticals USA
- Industry
- Enrollment
- 601 participants
Conditions and interventions
Conditions
Interventions
- Adapalene Drug
- Differin® Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2007
- Primary completion
- Mar 31, 2008
- Completion
- Mar 31, 2008
- Last update posted
- Nov 23, 2010
2007 – 2008
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermatology Research of Arkansas | Little Rock | Arkansas | 72205 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Cherry Creek Research, Inc. | Denver | Colorado | 80209 | — |
| University Clinical Research, Inc. | Pembroke Pines | Florida | 33024 | — |
| MedaPhase, Inc. | Newnan | Georgia | 30263 | — |
| SNBL Clinical Pharmacology Center, Inc. | Baltimore | Maryland | 21201 | — |
| Michigan Center for Research Corportation | Clinton Township | Michigan | 48038 | — |
| Office of Atoya Breona Adams, MD | Las Vegas | Nevada | 89119 | — |
| Academic Dermatology Associates | Albuquerque | New Mexico | 87106 | — |
| Helendale Dermatology & Medical Spa, LLC | Rochester | New York | 14609 | — |
| Dermatology Associates of Rochester, PC | Rochester | New York | 14623 | — |
| Office of Zoe Diana Draelos, MD | High Point | North Carolina | 27262 | — |
| University Dermatology Consultants, Inc. | Cincinnati | Ohio | 45219 | — |
| Novum Pharmaceutical Research Services | Pittsburgh | Pennsylvania | 15206 | — |
| Knoxville Dermatology, PC | Knoxville | Tennessee | 37920 | — |
| Arlington Center for Dermatology | Arlington | Texas | 76011 | — |
| Center for Clinical Studies | Houston | Texas | 77030 | — |
| Center for Clinical Studies | Houston | Texas | 77058 | — |
| Dermatology Associates of Tyler | Tyler | Texas | 75701 | — |
| Aurora Advanced Healthcare, Inc. | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01182636, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 23, 2010 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01182636 live on ClinicalTrials.gov.